Literature DB >> 12764351

Effect of bcl-2 antisense oligodeoxynucleotides on drug sensitivity of leukemic cells.

Yuan Zhang1, Xiao Yong Lei.   

Abstract

INTRODUCTION: We investigated the effect of two antisense oligodeoxynucleotides, previously selected with the help of computer-aided RNA structure prediction, on drug sensitivity, bcl-2 expression and apoptosis of leukemia cells. The drugs tested were etoposide (VP-16), cytarabine (Ara-C), daunorubicin (DNR) and arsenic trioxide (As(2)O(3)).
MATERIALS AND METHODS: The experimental assays were performed with cultures, IC(50) of leukemic cells to drugs, immunochemistry and flow cytometry.
RESULTS: The results showed that the two antisense oligodeoxynucleotides significantly reduced IC(50) levels for VP-16, Ara-c, DNA and As(2)O(3), inhibited bcl-2 gene expression and induced apoptosis of leukemic cells.
CONCLUSIONS: Computational prediction of antisense efficacy is faster than other methods and more cost-efficient. This could hasten the development of sequences for both research and clinical applications.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12764351     DOI: 10.1038/sj.thj.6200245

Source DB:  PubMed          Journal:  Hematol J        ISSN: 1466-4860


  2 in total

1.  Antisense bcl-2 transfection up-regulates anti-apoptotic and anti-oxidant thioredoxin in neuroblastoma cells.

Authors:  Yiting Li; Zhaohui Lu; Fang Chen; Jian Guan; Liping Hu; Yanfeng Xu; Jie Chen
Journal:  J Neurooncol       Date:  2005-03       Impact factor: 4.130

Review 2.  Bcl-2 antisense therapy in B-cell malignant proliferative disorders.

Authors:  Asher Chanan-Khan; Myron S Czuczman
Journal:  Curr Treat Options Oncol       Date:  2004-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.